Cognizant to acquire Zenith Technologies

Company |  News | 0 Comment | 19 Jun, 2019

Cognizant has agreed to acquire Zenith Technologies, a privately-held life sciences manufacturing technology Services Company. Zenith Technologies specializes in implementing...Read more

USFDA grants NAI to Centaur Pharma’s FD facility in Pune

Company |  News | 0 Comment | 17 Jun, 2019

Mumbai based Centaur Pharmaceuticals' finished dosage facility in Pune was audited by the USFDA in May 2019 and the audit was concluded with NIL 483 observations. The company received No Ac...Read more

Dr. Reddy’s to sell its neurology products to Upsher-Smith Labs

Company |  News | 0 Comment | 14 Jun, 2019

Dr. Reddy’s Laboratories Limited announces that it has entered into a definitive asset purchase agreement with Upsher-Smith Laboratories, LLC (Upsher-Smith), pursuant to which Dr. Red...Read more

Lupin positions itself to enter sterile injectables category

Company |  News | 1 Comment | 13 Jun, 2019

With flexibility in both the operation and supply chain, Mumbai based multi national pharmaceutical company Lupin is now well-positioned to make their entry into the sterile injectable prod...Read more

Merck to Acquire Tilos Therapeutics

Company |  News | 0 Comment | 11 Jun, 2019

Merck known as MSD outside the United States and Canada has announced that it has entered into a definitive agreement to acquire Tilos Therapeutics, a privately held biopharmaceutical compa...Read more

FDA approves Elli Lilly’s Emgality® (galcanezumab-gnlm) for Episodic Cluster Headache

Company |  News | 0 Comment | 07 Jun, 2019

Eli Lilly and Company has announced that the U.S. Food and Drug Administration (FDA) has approved Emgality®(galcanezumab-gnlm) injection (300 mg) for the treatment of epi...Read more

NATCO settles generic Carfilzomib Injection patent litigation in US

Company |  News | 0 Comment | 05 Jun, 2019

NATCO Pharma Limited is pleased to announce that it has reached a Settlement Agreement with Onyx Therapeutics, Inc. on patent litigation related to generic versions of 10mg, 30mg and 60mg o...Read more

Bio-Techne to acquire B-MoGen Biotechnologies Inc.

Company |  News | 0 Comment | 05 Jun, 2019

Bio-Techne Corporation announced it has reached agreement to acquire all of the stock of B-MoGen Biotechnologies Inc. The transaction has been completed and is being financed through availa...Read more

Lupin wins Packaging Award for its patient awareness initiative ‘Lupin Sahayak’

Company |  News | 0 Comment | 04 Jun, 2019

Lupin has announced that it has won the India Packaging Award 2019 for its patient awareness initiative ‘Lupin Sahayak’ and its special packaging for Telista. Telista is L...Read more

Cadila Pharma receives GLP certificate from government

Company |  News | 0 Comment | 03 Jun, 2019

Cadila Pharma recently received the Good Laboratory Practices Certification from National Good Laboratory Practice (GLP) compliance Monitoring Authority (NGCMA), Dept. of Science and Techno...Read more

Novartis gets FDA approval for gene therapy labeled at $2M

Company |  News | 0 Comment | 31 May, 2019

AveXis, a Novartis company, has announced the US Food and Drug Administration (FDA) has approved Zolgensma®(onasemnogene abeparvovec-xioi) for the treatment of pediatric patients l...Read more

Zydus gets final approval from the USFDA for acid reflux drug

Company |  News | 0 Comment | 24 May, 2019

Zydus Cadila has received the final approval from the USFDA to market Esomeprazole Magnesium Delayed-Release Capsules USP (US RLD – NEXIUM), 25 mg and 40 mg. It will be manufactured ...Read more

Lupin launches Budesonide Inhalation Suspension

Company |  News | 0 Comment | 24 May, 2019

Lupin has announced the launch of its Budesonide Inhalation Suspension, 0.5 mg/2 mL Single-Dose Ampules in the US market, having received an approval from the United States Food and Drug Ad...Read more

Health Canada approves Biocon and Mylan’s Ogivri

Company |  News | 0 Comment | 23 May, 2019

Biocon Ltd. and Mylan N.V. have announced that Health Canada has approved Mylan’s Ogivri™ (trastuzumab), a biosimilar to Herceptin® (trastuzumab) co-developed with...Read more

Nestlé enters into exclusive negotiations to sell Nestlé Skin Health

Company |  News | 0 Comment | 17 May, 2019

Nestlé announced that it has entered into exclusive negotiations with a consortium led by EQT and a wholly owned subsidiary of the Abu Dhabi Investment Authority (ADIA) for the sale ...Read more

Thermo Fisher to acquire GSK API Site for €90 M

Company |  News | 0 Comment | 17 May, 2019

Thermo Fisher Scientific Inc. the world leader in serving science, has entered into a definitive agreement to acquire a drug substance manufacturing site in Cork, Ireland, from GlaxoSm...Read more

Roche gets FDA approval for Venclexta plus Gazyva

Company |  News | 0 Comment | 16 May, 2019

Roche announced that the US Food and Drug Administration (FDA) has approved Venclexta® (venetoclax) in combination with Gazyva®(obinutuzumab) for the treatment of people with p...Read more

Dr. Reddy's launches Daptomycin for Injection

Company |  News | 0 Comment | 15 May, 2019

Dr. Reddy’s Laboratories Ltd. announced the launch of Daptomycin for Injection, 500mg/vial single-dose vial, a therapeutic equivalent generic version of Cubicin® for Inj...Read more